Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Consumer durables shares extend losses for a third consecutive session.
At 10:25 IST, the barometer index, the S&P BSE Sensex declined 832.12 points or 1.10% to 74,413.21 The Nifty 50 index dropped 261.20 points or 1.10% to 23,382.30.
The broader market underperformed the frontline indices. The BSE 150 MidCap Index tumbled 1.66% and the BSE 250 SmallCap Index dropped 2.57%.
The market breadth was negative. On the BSE, 764 shares rose and 3,102 shares fell. A total of 204 shares were unchanged.
In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 96.2300 compared with its previous close of 95.8100. It also touched an all-time intraday low of 96.25 today.
In the commodities market, Brent crude for July 2026 settlement rose $1.83 cents or 1.67% to $111.09 a barrel.
Earnings to Watch:
Indian Oil Corporation(down 2.42%), Afcons Infrastructure(down 6.87%), Ola Electric Mobility(down 3.17%), Apollo Micro Systems(down 2.16%), Indraprastha Gas(down 1.22%), JSW Cement(down 1.95%), Puravankara(down 1.90%), Sun Pharma Advanced Research Company(down 2.26%), Strides Pharma Science(down 1.81%), Baazar Style Retail (down 5.01%) and Zydus Wellness(down 2.94%) will announce their quarterly earnings today.
Buzzing Index:
The Nifty consumer durables index tumbled 3.34% to 34,366.50. The index fell 3.42% in the two consecutive trading sessions.
Amber Enterprises India (down 13.68%), PG Electroplast (down 5.56%), Blue Star (down 3.8%), Kalyan Jewellers India (down 3.41%), Crompton Greaves Consumer Electricals (down 2.86%), LG Electronics India (down 2.84%), Dixon Technologies (India) (down 2.4%), Havells India (down 2.38%), Bata India (down 2.27%) and Titan Company (down 2.05%) tumbled.
Stocks in Spotlight:
Gland Pharma surged 12.47% after the pharma company has reported 96.62% increase in consolidated net profit to Rs 366.7 crore on a 22.31% rise in net sales to Rs 1,742.80 crore in Q4 FY26 over Q4 FY25.
NCC slipped 5.22% after the company reported an 18.8% drop in consolidated net profit to Rs 206.02 crore in Q4 FY26, compared to Rs 253.82 crore recorded in Q4 FY25.
Gland Pharma Ltd, Premier Energies Ltd, Cohance Lifesciences Ltd, Shree Cement Ltd are among the other stocks to see a surge in volumes on BSE today, 18 May 2026.
J K Cements Ltd registered volume of 58311 shares by 10:46 IST on BSE, a 12.2 fold spurt over two-week average daily volume of 4779 shares. The stock slipped 1.11% to Rs.5,400.00. Volumes stood at 2233 shares in the last session.
Gland Pharma Ltd clocked volume of 1.95 lakh shares by 10:46 IST on BSE, a 8.25 times surge over two-week average daily volume of 23679 shares. The stock gained 15.41% to Rs.2,154.75. Volumes stood at 4285 shares in the last session.
Premier Energies Ltd clocked volume of 2.98 lakh shares by 10:46 IST on BSE, a 6.61 times surge over two-week average daily volume of 45115 shares. The stock gained 0.92% to Rs.990.40. Volumes stood at 27610 shares in the last session.
Cohance Lifesciences Ltd witnessed volume of 21.15 lakh shares by 10:46 IST on BSE, a 5.62 times surge over two-week average daily volume of 3.76 lakh shares. The stock dropped 1.69% to Rs.416.05. Volumes stood at 1.19 lakh shares in the last session.
Shree Cement Ltd notched up volume of 5187 shares by 10:46 IST on BSE, a 5.58 fold spurt over two-week average daily volume of 930 shares. The stock slipped 2.48% to Rs.24,348.85. Volumes stood at 539 shares in the last session.
Profit before tax stood at Rs 505.79 crore in Q4 FY26, up by 75.42% from Rs 288.33 crore recorded in Q4 FY25.
Consolidated EBITDA stood at Rs 513 crore in Q4 March 2026, registering the growth of 48% YoY with EBITDA margin of 29%.
R&D expenses stood at Rs 50.6 crore in Q4 FY26, accounting for 4% of base business revenue, and were primarily directed toward complex product development and filings. During the quarter, the company launched five molecules in the US, including Dalbavancin and Brimonidine, taking total US launches in FY26 to 31 products.
On the regulatory front, eight ANDA filings were made and 11 approvals were received in Q4 FY26, while FY26 saw 24 filings and 28 approvals, taking cumulative US ANDA filings to 388 (337 approved and 51 pending). The in-house complex pipeline continues to strengthen with six products already launched and three awaiting approval, with complex injectables expected to remain a key long-term growth driver.
Under co-development partnerships, 15 products are in development, including seven 505(b)(2) and eight ANDAs, with commercialization expected from FY28. The company also advanced its Ready-to-Use (RTU) bag portfolio with 21 filings, 18 approvals, and 11 products under development, addressing an estimated US market opportunity of $634 million.
In the GLP-1 and insulin analog segment, the company launched Liraglutide in the US, with pen/cartridge capacity at 140 million units per annum. Additionally, a new CDMO contract was signed for a complex nano drug delivery system-based injectable in oncology.
Srinivas Sadu, Executive Chairman of Gland Pharma, stated, “Our strong FY26 performance, reflected in consolidated revenue growth of 14.5% and an adjusted EBITDA margin of 26%, underscores the progress we are making across the businesses including Cenexi. The 38% adjusted EBITDA margin of base business has been supported by robust growth in the CDMO segment, alongside new product launches and improved profitability across our existing portfolio, driven by ongoing costefficiency initiatives. We remain confident in sustaining this momentum, supported by a pipeline of complex product launches and the continued ramp-up of CDMO partnerships.”
The board has recommended a final dividend of Rs 20 per equity share of face value Rs 1 each (2000%) for FY26. If approved, the dividend will be paid within 30 days from the date of the 48th Annual General Meeting. The record date for determining eligible shareholders has been fixed as Tuesday, August 11, 2026.
Gland Pharma was established in 1978 in Hyderabad and has grown over the years from a contract manufacturer of small-volume liquid parenteral products to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India, and other markets.
Great Eastern Shipping Company Ltd, Raymond Ltd, Arvind Ltd and Shipping Corporation of India Ltd are among the other gainers in the BSE's 'A' group today, 18 May 2026.
Gland Pharma Ltd surged 13.81% to Rs 2124.9 at 11:46 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 2.25 lakh shares were traded on the counter so far as against the average daily volumes of 14321 shares in the past one month.
Great Eastern Shipping Company Ltd soared 10.15% to Rs 1687.5. The stock was the second biggest gainer in 'A' group. On the BSE, 8.78 lakh shares were traded on the counter so far as against the average daily volumes of 1.1 lakh shares in the past one month.
Raymond Ltd spiked 7.44% to Rs 488.6. The stock was the third biggest gainer in 'A' group. On the BSE, 2.18 lakh shares were traded on the counter so far as against the average daily volumes of 74378 shares in the past one month.
Arvind Ltd exploded 5.45% to Rs 475.85. The stock was the fourth biggest gainer in 'A' group. On the BSE, 2.06 lakh shares were traded on the counter so far as against the average daily volumes of 69959 shares in the past one month.
Shipping Corporation of India Ltd spurt 4.86% to Rs 347.15. The stock was the fifth biggest gainer in 'A' group. On the BSE, 10.18 lakh shares were traded on the counter so far as against the average daily volumes of 10.2 lakh shares in the past one month.
Media, consumer durables, PSU Bank and auto shares declined while IT, pharma and private bank shares advanced.
As per provisional closing data, the barometer index, the S&P BSE Sensex advanced 77.05 points or 0.10% to 75,315.04. The Nifty 50 index rose 6.45 points or 0.03% to 23,649.95.
The broader market underperformed the frontline indices. The BSE 150 MidCap Index fell 0.43% and the BSE 250 SmallCap Index declined 1.71%.
The market breadth was weak. On the BSE, 1,265 shares rose and 3,032 shares fell. A total of 206 shares were unchanged.
In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 96.3400 compared with its previous close of 95.8100. It also touched an all-time intraday low of 96.3900 today.
In the commodities market, Brent crude for July 2026 settlement rose 80 cents or 0.73% to $110.06 a barrel.
The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, added 4.47% to 19.63.
Economy:
India's forex reserves rose by $6.295 billion to $ 696.988 billion during the week ended May 8, the Reserve Bank said on Friday. The overall reserves had dropped by $7.794 billion to $690.693 billion in the previous reporting week. The forex kitty had hit an all-time high of $ 728.494 billion during the week ended February 27 this year, before the onset of the West Asia crisis.
For the week ended May 8, the foreign currency assets, a major component of the reserves, increased by $562 million to $552.387 billion. Value of gold reserves soared by $5.637 billion to $120.853 billion during the week, the RBI said. The Special Drawing Rights (SDRs) also rose by $84 million to $18.873 billion.
The Nifty media index declined 2.25% to 1,403.85. The index jumped 2.89% in the past two trading sessions.
Saregama India (down 5.74%), Prime Focus (down 4.99%), Zee Entertainment Enterprises (down 4.19%), Sun TV Network (down 2.6%), Network 18 Media & Investments (down 2.2%), Hathway Cable & Datacom (down 1.95%), Nazara Technologies (down 0.55%), Tips Music (down 0.26%) and PVR Inox (down 0.1%) declined.
Gland Pharma surged 15.19% after the company has reported 96.62% increase in consolidated net profit to Rs 366.7 crore on a 22.31% rise in net sales to Rs 1,742.80 crore in Q4 FY26 over Q4 FY25.
VIP Industries declined 3.96% after the company’s consolidated net loss widened to Rs 128.90 crore in Q4 FY26 as against a net loss of Rs 27.36 crore reported in Q4 FY25. Revenue from operations declined 11.7% year on year (YoY) to Rs 436.23 crore in the quarter ended 31 March 2026.
Bharat Wire Ropes dropped 3.61% after the company’s standalone net profit slipped 20.09% to Rs 16.46 crore in Q4 FY26 as against 20.60 crore in Q4 FY25. Revenue from operations fell 17.66% to Rs 141.48 crore in the quarter ended 31 March 2026.
Neogen Chemicals rose 0.94% after the company reported resilient operational performance in Q4 FY26 despite elevated input costs, Dahej transition-related expenses and geopolitical supply chain disruptions.
Vodafone Idea rose 0.23%. The company has reported a consolidated net profit of Rs 51,970 crore in Q4 FY26 as against a net loss of Rs 7,167 crore in Q4 FY25. Revenue rose by 3.2% year-on-year (YoY) to Rs 11,303 crore in Q4 FY26. The customer ARPU increased to Rs 190 in Q4 FY26 compared to Rs 175 in Q4 FY25, a YoY increase of 8.3%.
KEC International tumbled 10.71% after the company reported a 28.11% fall in consolidated net profit to Rs 192.79 crore for the quarter ended 31 March 2026, compared with Rs 268.19 crore posted in the corresponding quarter last year.
Cochin Shipyard tanked 4.92% after it has reported an 3.72% decline in consolidated net profit to Rs 276.48 crore on a 15.55% decrease in revenue from operations to Rs 1,484.27 crore in Q4 FY26 over Q4 FY25.
Steel Authority of India fell 1.17%. The company reported a 42.57% year-on-year rise in standalone net profit to Rs 1,679.51 crore for the fourth quarter ended 31 March 2026, compared with Rs 1,177.96 crore in the corresponding quarter last year. Revenue from operations rose 5.10% to Rs 30,813.45 crore in the quarter ended 31 March 2026.
HDFC Asset Management Company declined 3.24% after the company disclosed a cyber-security incident involving certain portions of its IT infrastructure. In an exchange filing, the company said it received a communication from an anonymous source on 16 May 2026 claiming access to parts of its IT systems.
Global Markets:
The US Dow Jones index futures are currently down by 311 points, signaling a negative opening for US stocks today.
Most European market advanced as investors will monitor the upcoming G7 finance ministers and central bank governors’ meeting in Paris on 18-19 May 2026.
Asian markets ended lower on Monday as investors weighed renewed geopolitical tensions after U.S. President Donald Trump warned Iran to 'get moving, FAST,” raising fears of further escalation in the Middle East and potential disruptions to global oil supplies.
In a post on Truth Social, Trump on Sunday said “the Clock is Ticking” for Iran and warned there “won’t be anything left” if action was not taken soon, adding that “TIME IS OF THE ESSENCE!” He did not elaborate on the steps he wanted Iran to take or the consequences that could follow.
Tensions between Washington and Tehran have remained elevated despite a fragile ceasefire reached in early April. The U.S. has continued its blockade of Iranian ports, while Iran has kept the Strait of Hormuz shut since the conflict began.
Last week on Wall Street, the major indices closed lower on Friday, weighed down by losses in technology stocks and a rise in U.S. Treasury yields after a summit between President Donald Trump and Chinese President Xi Jinping ended without major policy breakthroughs, leaving traders worried.
The S&P 500 shed 1.24% to end at 7,408.50, while the Nasdaq Composite slipped 1.54% to 26,225.14. The Dow Jones Industrial Average was down 537.29 points, or 1.07%, and closed at 49,526.17.
Great Eastern Shipping Company Ltd, Premier Energies Ltd, ICICI Prudential Life Insurance Company Ltd, Amber Enterprises India Ltd are among the other stocks to see a surge in volumes on NSE today, 18 May 2026.
Gland Pharma Ltd notched up volume of 52.97 lakh shares by 14:14 IST on NSE, a 27.13 fold spurt over two-week average daily volume of 1.95 lakh shares. The stock rose 14.05% to Rs.2,130.80. Volumes stood at 1.42 lakh shares in the last session.
Great Eastern Shipping Company Ltd clocked volume of 152.92 lakh shares by 14:14 IST on NSE, a 9.69 times surge over two-week average daily volume of 15.78 lakh shares. The stock gained 10.07% to Rs.1,688.30. Volumes stood at 97.54 lakh shares in the last session.
Premier Energies Ltd registered volume of 48.25 lakh shares by 14:14 IST on NSE, a 5.44 fold spurt over two-week average daily volume of 8.87 lakh shares. The stock rose 1.56% to Rs.996.90. Volumes stood at 7.51 lakh shares in the last session.
ICICI Prudential Life Insurance Company Ltd notched up volume of 56.33 lakh shares by 14:14 IST on NSE, a 5.24 fold spurt over two-week average daily volume of 10.75 lakh shares. The stock slipped 3.02% to Rs.519.45. Volumes stood at 4.82 lakh shares in the last session.
Amber Enterprises India Ltd saw volume of 18.39 lakh shares by 14:14 IST on NSE, a 5.13 fold spurt over two-week average daily volume of 3.59 lakh shares. The stock dropped 14.67% to Rs.7,233.00. Volumes stood at 3.79 lakh shares in the last session.
For the full year,net profit rose 47.07% to Rs 1027.32 crore in the year ended March 2026 as against Rs 698.53 crore during the previous year ended March 2025. Sales rose 14.50% to Rs 6430.65 crore in the year ended March 2026 as against Rs 5616.50 crore during the previous year ended March 2025.
Shares of Gland Pharma fell 1.80% to end at Rs 1,861 on the BSE.